Gustatory sweating, or Frey's syndrome, usually occurs after surgery or trauma to the parotid gland as a result of inappropriate parasympathetic cholinergic innervation of cutaneous sympathetic receptors. Numerous medical and surgical treatments have been proposed to prevent or treat this condition. The results, overall, have been unsatisfactory. Botulinum toxin is a relatively new treatment modality for Frey's syndrome. We review the literature and present our experience with 7 patients successfully treated with intradermal injections of botulinum toxin (Botox). Our technique and dosing are described. In all treated patients gustatory sweating ceased in the area injected with botulinum toxin. In 6 patients, symptoms reappeared, and additional injections were needed up to 4 times, at 6- to 8-month intervals. All patients now have been free of symptoms for a long period of time (mean 12.1 months). We strongly recommend intradermal injections of botulinum toxin as a safe, efficacious treatment for gustatory sweating.
Get full access to this article
View all access options for this article.
References
1.
. FreyL. Le syndrome du nerf auriculotemporal. Rev Neurol (Paris)1923; 30: 97–104.
2.
. SpiroRHMartinH. Gustatory sweating following parotid surgery and radical neck dissection. Ann Surg1967; 165: 118–27.
. Laage-HellmanJE. Treatment of gustatory sweating and flushing. Acta Otolaryngol1958; 49: 132.
5.
. FordFRWoodhallR. Phenomena due to misdirection of regenerating fibers of cranial, spinal and automatic nerves: clinical observations. Arch Surg1938; 69: 54.
6.
. HaysLLNovackAJWorshamJC. The Frey syndrome: a simple, effective treatment. Otolaryngol Head Neck Surg1982; 90: 419.
7.
. KohnblutADWestphalPMiehlkeA. The effectiveness of a ster-nomastoid muscle flap in preventing postparotidectomy occurrence of Frey syndrome. Acta Otolaryngol1974; 77: 368–73.
. HaradaTInoueTHarashinaT, Dermis-fat graft after parotidectomy to prevent Frey's syndrome and the concave deformity. Ann Plast Surg1993; 33: 450–2.
10.
. ShemenLJ. Expanded polytef for reconstructing postparotidectomy defects and preventing Frey's syndrome. Arch Otolaryngol Head Neck Surg1995; 121: 1307–9.
11.
. SultanMRWiderTMHugoNE. Frey's syndrome: prevention with temporoparietal facial flap interposition. Ann Plast Surg1995; 34: 292–7.
12.
. Laage-HellmanJE. Gustatory sweating and flushing. Aetiological implications of response of separate sweat glands to various stimuli. Acta Otolaryngol (Stockh)1958; 49: 306–14.
13.
. ParisierSCBinderWJBlitzerA, Evaluation of tympanic neurectomy and chordatympanectomy for gustatory sweating and benign salivary gland disease. Ear Nose Throat J1978; 57: 213–23.
14.
. SmithROJrHemmenwayWCStevensKM, Jacobson's neurectomy for Frey's syndrome. Am J Surg1970; 120: 478–81.
15.
. KiddHA. Total parotidectomy with preservation of facial nerve. A review of 47 cases. BMJ1955; 2: 1309.
. DrobikCLaskawiRSchwabS. Die therapie des Frey-syndrome mit Botulinumtoxin A. HNO1995; 43: 644–8.
20.
. SessionsRBRoaarkDTAlfordBR. Frey's syndrome: a technical remedy. Ann Otolaryngol1976; 85: 735–9.
21.
. WallisKAGibsonT. Gustatory sweating following parotidectomy correction by a fascia lata graft. Br J Plast Surg1978; 31: 68–71.
22.
. WalterC. The free dermis fat transplantation as adjunct in the surgery of the parotid gland. Laryngorhinootologie (Stuttg)1975; 90: 419–25.
23.
. HaysLL. The Frey syndrome: a review and double blind evaluation of the topical use of a new anticholinergic agent. Laryngo-scope1978; 88: 1796–824.
24.
. MayJSMcguirtW. Frey's syndrome treatment with topical glycopyrrolate. Head Neck1989; 11: 85–9.
25.
. LaccourreyeOBonanBBrasnuD, Treatment of Frey's syndrome with topical 2% diphemanil methylsulfate (Prantal): a double blind evaluation of 15 patients. Laryngoscope1990; 100: 651–3.
26.
. HuttenbrinkKB. Die therapie des gustatorischen Schwitzens nach parotidectomie. Laryngorhinootologie (Stuttg)1986; 65: 135–7.
27.
. ColdwaterKB. Treatment of the auriculo-temporal syndrome. Arch Surg1954; 96: 54–7.
28.
. ValtortaFArslanG. The pharmacology of botulinum toxin at the neuromuscular junction. Pharmacol Res1993; 27: 33–44.
29.
. SellinLC. The action of botulinum toxin at the neuromuscular junction. Med Biol1981; 59: 11–2.
30.
. LaskawiRDrobikCSchonebeckC. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope1998; 108: 381–4.
